# Evaluation of centralised and decentralised models of care during the 2020 Ebola Virus Disease outbreak in Equateur Province, Democratic Republic of the Congo: A brief report

**Authors:** Emmanuel Lampaert, Justus Nsio Mbeta, Divya Nair, Maria Mashako, Anja De Weggheleire, Armand Sprecher, Rebecca M. Coulborn, Steve Ahuka-Mundeke, Nlandu Roger Ngatu, Divya Nair, Francesco Branda, Divya Nair

PMC · DOI: 10.12688/f1000research.150755.1 · F1000Research · 2024-06-17

## TL;DR

This study compares centralized and decentralized Ebola treatment models in the DRC during the 2020 outbreak, finding that decentralized care improved early patient access.

## Contribution

The paper evaluates the effectiveness of decentralized treatment centers in improving access and reducing delays in Ebola care.

## Key findings

- Decentralized treatment centers reduced the time from symptom onset to admission compared to centralized centers.
- Only 2% of patients in decentralized centers were confirmed with Ebola, suggesting better screening is needed.
- Decentralized care may be beneficial in remote areas to improve early access and outbreak control.

## Abstract

Traditionally in the Democratic Republic of the Congo (DRC), centralised Ebola treatment centres (ETCs) have been set exclusively for Ebola virus disease (EVD) case management during outbreaks. During the 2020 EVD outbreak in DRC’s Equateur Province, existing health centres were equipped as decentralised treatment centres (DTC) to improve access for patients with suspected EVD. Between ETCs and DTCs, we compared the time from symptom onset to admission and diagnosis among patients with suspected EVD.

This was a cohort study based on analysis of a line-list containing demographic and clinical information of patients with suspected EVD admitted to any EVD health facility during the outbreak.

Of 2359 patients with suspected EVD, 363 (15%) were first admitted to a DTC. Of 1996 EVD-suspected patients initially admitted to an ETC, 72 (4%) were confirmed as EVD-positive. Of 363 EVD-suspected patients initially admitted to a DTC, 6 (2%) were confirmed and managed as EVD-positive in the DTC. Among all EVD-suspected patients, the median (interquartile range) duration between symptom onset and admission was 2 (1-4) days in a DTC compared to 4 (2-7) days in an ETC (p<0.001). Similarly, time from symptom onset to admission was significantly shorter among EVD-suspected patients ultimately diagnosed as EVD-negative.

Since <5% of the EVD-suspected patients admitted were eventually diagnosed with EVD, there is a need for better screening to optimise resource utilization and outbreak control. Only one in seven EVD-suspected patients were admitted to a DTC first, as the DTCs were piloted in a limited and phased manner. However, there is a case to be made for considering decentralized care especially in remote and hard-to-reach areas in places like the DRC to facilitate early access to care, contain viral shedding by patients with EVD and ensure no disrupted provision of non-EVD services.

## Linked entities

- **Diseases:** Ebola virus disease (MONDO:0005737)

## Full-text entities

- **Diseases:** EVD (MESH:D019142)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11406140/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11406140/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC11406140/full.md

---
Source: https://tomesphere.com/paper/PMC11406140